UnitedHealth Group Inc. (NYSE:UNH) issued an update on its FY16 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of ~$8.00 for the period, compared to the Thomson Reuters consensus estimate of $7.92.
UnitedHealth Group Inc. (NYSE:UNH) opened at 134.13 on Tuesday. The company has a 50-day moving average of $136.95 and a 200 day moving average of $136.65. The company has a market cap of $127.74 billion, a PE ratio of 20.99 and a beta of 0.57. UnitedHealth Group Inc. has a 52-week low of $107.51 and a 52-week high of $144.48.
UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Tuesday, October 18th. The healthcare conglomerate reported $2.17 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $2.08 by $0.09. The firm had revenue of $46.30 billion for the quarter, compared to analysts’ expectations of $46.06 billion. UnitedHealth Group had a net margin of 3.51% and a return on equity of 19.08%. The business’s revenue was up 11.6% on a year-over-year basis. During the same period in the prior year, the firm earned $1.77 EPS. Equities research analysts predict that UnitedHealth Group Inc. will post $7.90 EPS for the current year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, September 20th. Shareholders of record on Friday, September 9th were issued a $0.625 dividend. The ex-dividend date of this dividend was Tuesday, September 6th. This represents a $2.50 annualized dividend and a yield of 1.86%. UnitedHealth Group’s dividend payout ratio is currently 39.12%.
Several research firms have weighed in on UNH. Oppenheimer Holdings Inc. reissued an outperform rating and issued a $161.00 price target (up from $145.00) on shares of UnitedHealth Group in a report on Friday, July 22nd. Barclays PLC increased their price target on shares of UnitedHealth Group from $151.00 to $164.00 and gave the company an overweight rating in a report on Wednesday, July 20th. Citigroup Inc. increased their price target on shares of UnitedHealth Group from $148.00 to $164.00 and gave the company a buy rating in a report on Wednesday, July 20th. Argus raised shares of UnitedHealth Group from a hold rating to a buy rating and set a $170.00 price target on the stock in a report on Friday, July 22nd. Finally, Zacks Investment Research raised shares of UnitedHealth Group from a hold rating to a buy rating and set a $160.00 price target on the stock in a report on Friday, July 22nd. One equities research analyst has rated the stock with a hold rating, twenty-five have given a buy rating and one has issued a strong buy rating to the company. The stock currently has an average rating of Buy and an average target price of $155.35.
In related news, Director Richard T. Burke sold 40,000 shares of UnitedHealth Group stock in a transaction on Wednesday, September 7th. The shares were sold at an average price of $135.31, for a total transaction of $5,412,400.00. Following the completion of the transaction, the director now owns 2,003,550 shares of the company’s stock, valued at $271,100,350.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 1.65% of the company’s stock.
A number of institutional investors have recently made changes to their positions in UNH. AXA increased its position in shares of UnitedHealth Group by 4.9% in the second quarter. AXA now owns 1,053,508 shares of the healthcare conglomerate’s stock worth $148,755,000 after buying an additional 49,280 shares in the last quarter. GAM Holding AG increased its position in shares of UnitedHealth Group by 24.2% in the second quarter. GAM Holding AG now owns 285,177 shares of the healthcare conglomerate’s stock worth $40,267,000 after buying an additional 55,524 shares in the last quarter. Atlantic Trust Group LLC increased its position in shares of UnitedHealth Group by 1.7% in the second quarter. Atlantic Trust Group LLC now owns 1,063,265 shares of the healthcare conglomerate’s stock worth $150,133,000 after buying an additional 17,444 shares in the last quarter. Van Hulzen Asset Management LLC purchased a new position in shares of UnitedHealth Group during the second quarter worth $104,000. Finally, Engineers Gate Manager LP increased its position in shares of UnitedHealth Group by 634.5% in the second quarter. Engineers Gate Manager LP now owns 21,300 shares of the healthcare conglomerate’s stock worth $3,008,000 after buying an additional 18,400 shares in the last quarter. 85.80% of the stock is owned by institutional investors and hedge funds.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated is a diversified healthcare company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. The Company conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.
Receive News & Ratings for UnitedHealth Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.